Research Article

Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota

Figure 2

JGXZ treatment reduced body weight gain and improved liver steatosis in NAFLD model rats. (a) Body weight gain was reduced in NAFLD model rats after treatment with JGXZ. (b) JGXZ treatment decreased the liver index in NAFLD model rats. (c) H&E staining indicated that JGXZ treatment ameliorated liver steatosis in NAFLD model rats (200 × and 400 ×). (d, e) The liver lipid contents were decreased in NAFLD model rats after JGXZ treatment (100 ×). Control, model, JGXZ low-dose, and JGXZ high-dose groups (n = 10 per group). Data are presented as the mean ± SD. # compared to the control group; compared to the control group; compared to the experimental model group; and compared to the experimental model group.
(a)
(b)
(c)
(d)
(e)